Stereotaxis (STXS) Liabilities and Shareholders Equity (2010 - 2026)

Stereotaxis (STXS) reported Liabilities and Shareholders Equity of $54.0 million for Q1 2026, up 18.21% year-over-year from $45.7 million in Q1 2025, and up 3.4% quarter-over-quarter from $52.3 million in Q4 2025.

Stereotaxis (STXS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $54.0 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $54.0 million, up 18.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $193.0 million (up 7.62% YoY), and the FY2025 annual result was $52.3 million, up 11.83% from the prior year.
  • Liabilities and Shareholders Equity rose to $54.0 million in Q1 2026 per STXS's latest filing, from $52.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $57.4 million in Q1 2022 and troughed at $36.0 million in Q2 2024.
  • A 5-year average of $48.3 million and a median of $48.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity dropped 25.46% in 2024, then rose 18.21% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $53.4 million in 2022, then decreased by 21.54% to $41.9 million in 2023, then climbed by 11.49% to $46.7 million in 2024, then increased by 11.83% to $52.3 million in 2025, then advanced by 3.4% to $54.0 million in 2026.
  • Business Quant data shows STXS's Liabilities and Shareholders Equity at $54.0 million in Q1 2026, $52.3 million in Q4 2025, and $45.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 20.11 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 50.83 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 39.01 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 8.78 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 4.11 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 14.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 12.48 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 6.31 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 19.85 Bn
10 Stereotaxis 180.48 Mn 165.86 Mn 3.79 Mn 54.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 54.03 Mn
Dec 31, 2025 52.25 Mn
Sep 30, 2025 45.59 Mn
Jun 30, 2025 41.17 Mn
Mar 31, 2025 45.71 Mn
Dec 31, 2024 46.72 Mn
Sep 30, 2024 50.94 Mn
Jun 30, 2024 36.01 Mn
Mar 31, 2024 39.45 Mn
Dec 31, 2023 41.91 Mn
Sep 30, 2023 44.53 Mn
Jun 30, 2023 48.32 Mn
Mar 31, 2023 50.71 Mn
Dec 31, 2022 53.41 Mn
Sep 30, 2022 56.08 Mn
Jun 30, 2022 56.68 Mn
Mar 31, 2022 57.43 Mn
Dec 31, 2021 60.99 Mn
Sep 30, 2021 61.92 Mn
Jun 30, 2021 57.34 Mn